0001209191-24-001980.txt : 20240119 0001209191-24-001980.hdr.sgml : 20240119 20240119210411 ACCESSION NUMBER: 0001209191-24-001980 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240119 FILED AS OF DATE: 20240119 DATE AS OF CHANGE: 20240119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morgan Adam CENTRAL INDEX KEY: 0001964335 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33221 FILM NUMBER: 24546919 MAIL ADDRESS: STREET 1: 1055B POWERS PLACE CITY: ALPHARETTA STATE: GA ZIP: 30009 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/ CENTRAL INDEX KEY: 0000818033 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 942875566 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582514400 MAIL ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: AP PHARMA INC /DE/ DATE OF NAME CHANGE: 20010511 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-19 0 0000818033 HERON THERAPEUTICS, INC. /DE/ HRTX 0001964335 Morgan Adam 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 1 0 0 0 0 Common Stock 2024-01-19 4 A 0 13948 0.00 A 51827 D Common Stock 6986744 I By Velan Capital Master Fund LP Stock Option (Right to Buy) 2.09 2024-01-19 4 A 0 83685 0.00 A 2034-01-19 Common Stock 83685 83685 D The shares were granted as restricted stock units which vest in full on January 19, 2025. Securities owned directly by Velan Master. Mr. Morgan, as a managing member of each of Velan Capital Holdings LLC, the general partner of Velan Master, and Velan Capital Management LLC, the general partner of the investment manager of Velan Master, may be deemed to beneficially own the securities owned directly by Velan Master. Mr. Morgan disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that Mr. Morgan is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. /s/ Lisa Peraza Attorney-in-fact for Adam Morgan 2024-01-19